Metastasis in von Hippel-Lindau disease

Journal of Neurosurgery

Volumn 109, Issue 3, 2008, Pages 568-

  Sorscher, Steven M ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEMANGIOBLASTOMA; HUMAN; KIDNEY CARCINOMA; METASTASIS; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; VON HIPPEL LINDAU DISEASE; BRAIN TUMOR; KIDNEY TUMOR; NEUROECTODERM TUMOR; NOTE; PATHOLOGY;

BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; HEMANGIOBLASTOMA; HUMANS; KIDNEY NEOPLASMS; NEUROECTODERMAL TUMORS, PRIMITIVE; VON HIPPEL-LINDAU DISEASE;

EID: 53449091086     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/JNS/2008/109/9/0568     Document Type: Article

References (4)

1. Jouanneau E: Angiogenesis and gliomas: current issues and the development of surrogate markers. Neurosurgery 62:31-52, 2008
2. Madhusudan S, Deplanque G, Braybrooke JP, Cattell E, Taylor M, Price P, et al: Antiangiogenic therapy for von Hippel-Lindau disease. JAMA 291:943-944, 2004 (Pubitemid 38543750)
3. Schuch G, de Wit M, Holtje J, Laack E, Schilling G, Hossfeld DK, et al: Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416. J Clin Oncol 23:3624-3626, 2005
4. Yao J: Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma. Best Pract Res Clin Endocrinol Metab 21:163-172, 2007